Practice-Changing Data in NSCLC from ASCO 2021

AACR & ASCO 2021 – Midyear Review

Videos Year in Review

Mark A. Socinski, MD

Executive Medical Director
AdventHealth Cancer Institute
Orlando, FL

Dr Mark Socinski provides his insights into important new data on EGFR inhibitors and immunotherapy in the first-line setting for NSCLC.

Conference Correspondent Coverage is Brought to You by the Publishers of:

American Health & Drug Benefits

Journal of Hematology Oncology Pharmacy

Journal of Oncology Navigation & Survivorship

Oncology Practice Management

Personalized Medicine in Oncology

Learn more about our family of publications.

View Our Publications